Skip to main content
. 2023 May 24;63(11):3238–3247. doi: 10.1021/acs.jcim.2c01355

Table 3. Results on the Three Molecule Generation Tasks for the Four Additional Drug Targetsa.

  ADRB1 MOR A2A D2
(a) Docking Score Function ()
CVAE –4.581 (0.920) –4.962 (0.911) –4.545 (0.917) –5.151 (0.913)
GVAE - - - - - - - -
REINVENT -8.164 (0.831) -7.326 (0.821) -7.372 (0.821) -8.265 (0.815)
Train (50%) –12.084 (0.712) –8.340 (0.837) –7.725 (0.846) –10.118 (0.829)
Train (10%) –13.246 (0.534) –9.174 (0.843) –8.617 (0.858) –11.451 (0.828)
Train (1%) –13.929 (0.400) –9.959 (0.828) –9.839 (0.853) –12.416 (0.769)
ZINC (50%) –9.189 (0.866) –8.046 (0.870) –7.755 (0.874) –9.094 (0.869)
ZINC (10%) –10.361 (0.852) –8.959 (0.863) –8.807 (0.869) –10.341 (0.859)
ZINC (1%) –11.299 (0.844) –9.808 (0.857) –9.778 (0.869) –11.424 (0.847)
(b) Repulsion ()
CVAE 1.188 (0.916) 1.704 (0.912) 0.898 (0.911) 1.648 (0.914)
GVAE 1.433 (0.931) - - - - - -
REINVENT 2.370 (0.867) 2.163 (0.876) 2.355 (0.839) 2.225 (0.858)
Train (50%) 2.906 (0.834) 2.175 (0.851) 1.028 (0.826) 1.842 (0.850)
Train (10%) 1.656 (0.857) 1.301 (0.859) 0.804 (0.826) 1.214 (0.856)
Train (1%) 0.855 (0.829) 0.837 (0.856) 0.623 (0.817) 0.802 (0.832)
ZINC (50%) 2.111 (0.882) 1.874 (0.885) 1.174 (0.878) 1.661 (0.883)
ZINC (10%) 1.290 (0.890) 1.227 (0.896) 0.738 (0.876) 1.193 (0.892)
ZINC (1%) 0.765 (0.852) 0.845 (0.902) 0.530 (0.889) 0.807 (0.903)
(c) Hydrogen Bonding ()
CVAE 1.574 (0.918) 0.819 (0.907) 0.240 (0.909) 0.567 (0.909)
GVAE 4.930 (0.902) 3.412 (0.901) 2.114 (0.901) 2.489 (0.935)
REINVENT 2.906 (0.829) 1.915 (0.831) 1.155 (0.843) 1.964 (0.833)
Train (50%) 3.904 (0.727) 1.153 (0.848) 0.283 (0.852) 1.203 (0.849)
Train (10%) 5.071 (0.736) 1.883 (0.860) 0.928 (0.870) 2.061 (0.863)
Train (1%) 6.157 (0.734) 2.967 (0.843) 1.962 (0.852) 3.213 (0.784)
ZINC (50%) 1.888 (0.880) 1.609 (0.882) 0.750 (0.883) 1.780 (0.881)
ZINC (10%) 2.985 (0.882) 2.538 (0.886) 1.589 (0.884) 2.699 (0.885)
ZINC (1%) 4.407 (0.890) 3.815 (0.891) 2.621 (0.894) 3.817 (0.889)
a

The experimental setup is the same as in Table 2.